securities.stanford.edu/filings-case.html?id=106499

Feb 9, 2018 ... Bristol-Myers Squibb Company ... According to the Complaint, Bristol-Myers purportedly discovers, develops, ... Joseph Giugno, et al. v.

www.law360.com/articles/1025863/the-rise-in-event-driven-securities-class-actions

Mar 26, 2018 ... Giugno v. Bristol-Myers Squibb Company et al.[2] is another striking recent example of event-driven litigation. There, the company announced ...

www.davispolk.com/files/2018-04-26_quarterly_report_life_sciences_securities_litigation_activity_in_q1_2018.pdf

Apr 26, 2018 ... the subpoena could be due to the company's reimbursement communications with doctors. ..... Aradigm Corp., et al., .... Giugno v. ... On February 9, the plaintiff brought a putative class action suit against Bristol-Myers Squibb.

s21.q4cdn.com/104148044/files/doc_financials/annual_reports/2017/Bristol-Myers-Squibb-2017-10-K-FINAL.pdf

Oct 1, 2017 ... Indicate by check mark whether the registrant (1) has filed all reports required to be .... Bristol-Myers Squibb Company was incorporated under the laws of the State of ...... In February 2018, the Company became aware of a putative class action complaint, Joseph Giugno v. Bristol-Myers Squibb Co., et al.

caselaw.findlaw.com/us-6th-circuit/1878276.html

BRISTOL-MYERS SQUIBB COMPANY; Otsuka America Pharmaceutical, Inc., Defendants-Appellees. ..... Bell Atlantic Corp., et al. v. Twombly, 550 U.S. 544, 555, ...

www.sec.gov/Archives/edgar/data/14272/000001427218000055/bmy-20171231x10xk.htm

Bristol-Myers Squibb Company was incorporated under the laws of the State of ..... References to the EU throughout this Form 10-K include all EU member states during ...... commercial viability; and (v) changes in regulatory approval processes may ...... Bristol-Myers Squibb Co., et al. that was filed in the U.S. District for the ...

law.justia.com/cases/federal/district-courts/new-york/nysdce/1:2016cv05668/460419/67

Utts et al v. Bristol-Myers Squibb Company et al, No. 1:2016cv05668 - Document 67 (S.D.N.Y. 2017) case opinion from the Southern District of New York US ...

www.fool.com/investing/2018/12/31/better-buy-celgene-vs-bristol-myers-squibb.aspx

Dec 31, 2018 ... Celgene (NASDAQ:CELG) and Bristol-Myers Squibb (NYSE:BMY) ... and the company's late-stage pipeline finally looks poised to perform.

www.ftc.gov/enforcement/cases-proceedings/0110046/bristol-myers-squibb-company-matter

May 25, 2004 ... Bristol-Myers Squibb Company (BMS) settled charges that it engaged in illegal business practices to delay the entry of three low price generic ...